Login / Signup

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.

Patrick J LeaveyNadia N Issa LaackMark D KrailoAllen BuxtonRobert Lor RandallSteven G DuBoisDamon R ReedHolcombe E GrierDouglas S HawkinsBruce PawelHelen Ruth NadelRichard B WomerG Douglas LetsonMark BernsteinKenneth BrownAlexis MaciejPaul ChubaAtif A AhmedDaniel J IndelicatoDian WangNeyssa M MarinaRichard G GorlickKatherine A JanewayLeo Mascarenhas
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
While VTC added to five-drug interval compressed chemotherapy did not improve survival, these outcomes represent the best survival estimates to date for patients with previously untreated nonmetastatic Ewing sarcoma.
Keyphrases